Quinolone Analog Quadruplex DNA Binding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for cell proliferative disorders, such as cancer, lack effective methods to inhibit cell proliferation and induce apoptosis, particularly in pancreatic cancer, and existing methods for interacting with quadruplex DNA structures are limited in therapeutic efficacy.
Innovation Solution
Development of quinolone analogs that can inhibit cell proliferation and induce apoptosis by interacting with quadruplex structures in DNA, including the use of specific compounds with formulas (1), (2A), and (2B) that can bind to regions of DNA forming quadruplexes, thereby down-regulating oncogene expression and stabilizing quadruplex structures.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for cell proliferative disorders are used, then existing therapeutic methods are available, but they lack effective methods to inhibit cell proliferation and induce apoptosis particularly in pancreatic cancer
Solution Approach 1:
The patent modifies the chemical structure of quinolone compounds by changing parameters such as substituting fluorine atoms at different positions (e.g., 7-fluoro-8-azidoquinolone vs. 6-fluoro-8-azidoquinolone), adding various substituents (methoxy, chloro, bromo groups), and creating different ring structures to optimize both therapeutic efficacy and cancer type specificity. This allows the same base compound to be adapted for different cancer indications.
Solution Approach 2:
The invention divides the therapeutic approach into multiple discrete compound variants, each with specific structural modifications. Rather than using a single broad-spectrum treatment, the patent segments the solution into specialized compounds (e.g., Compounds 1-10 with different substituents) that can be selected based on the specific cancer type and quadruplex structure characteristics.
2Reliability
If existing methods for interacting with quadruplex DNA structures are used, then some interaction is achieved, but therapeutic efficacy is limited
Solution Approach 1:
The patent incorporates pre-functionalized groups into the quinolone core structure during synthesis, such as pre-installed fluorine atoms, azido groups, and substituent patterns that will later enhance quadruplex binding. This preliminary preparation of the molecular structure with specific binding motifs simplifies the overall drug development process and improves therapeutic efficacy without proportionally increasing manufacturing complexity.
3Reliability
If quinolone analogs are designed to target quadruplex DNA structures, then cell proliferation is inhibited and apoptosis is induced, but the structural complexity of the compounds increases
Solution Approach 1:
The quinolone core structure acts as an intermediary scaffold that mediates between the need for therapeutic activity and structural simplicity. By maintaining a relatively simple core quinolone structure and adding only essential functional groups (fluorine, azido, and minimal substituents), the compounds achieve effective quadruplex binding and anticancer activity without excessive molecular complexity. The core structure facilitates the interaction while keeping the overall molecule manageable.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The quinolone analogs effectively reduce cell proliferation and induce apoptosis in cancer cells, including pancreatic cancer cells, by targeting quadruplex DNA structures, offering a novel approach to treating cell proliferative disorders and potentially reducing microbial infections by stabilizing quadruplex structures and down-regulating oncogene expression.
Implementation Method 1
The compounds of present invention may or may not interact with regions of DNA that can form quadruplexes... stabilizing a native quadruplex structure... binding to regions of DNA that can form quadruplexes... stabilizing quadruplex structures
Data Source
AI summary
The present invention provides quinolone analogs which may inhibit cell proliferation and/or induce cell apoptosis. The present invention also provides methods of preparing quinolone analogs, and methods of using the same.